搜索临床试验以:SPI-2012
总计2545个结果
-
Spectrum Pharmaceuticals, Inc完全的
-
Spectrum Pharmaceuticals, Inc完全的乳腺癌 | 中性粒细胞减少症美国, 加拿大, 大韩民国
-
Spectrum Pharmaceuticals, Inc完全的
-
Stanford UniversityNational Institute of Allergy and Infectious Diseases (NIAID)完全的
-
GlaxoSmithKline完全的
-
Quark Pharmaceuticals终止非动脉性前部缺血性视神经病变美国, 澳大利亚, 德国, 中国, 印度, 意大利, 新加坡, 以色列
-
Ybrain Inc.Gangnam Severance Hospital; Severance Hospital; CHA University; Hallym University Medical Center; National... 和其他合作者完全的
-
Universitätsklinikum Hamburg-Eppendorf招聘中
-
University of Sao Paulo General HospitalD'Antonio Consultants International, Inc.; Sao Paulo, Secretaria de Estado da Saúde未知
-
Beta Pharma Shanghai完全的
-
Fusion Pharmaceuticals Inc.招聘中宫颈癌 | 乳腺癌 | 卵巢癌 | 子宫内膜癌 | 葡萄膜黑色素瘤 | 肾上腺皮质癌 | 晚期实体瘤 | HER2 阴性乳腺癌 | 三阴性乳腺癌 (TNBC) | 头颈部鳞状细胞癌 (HNSCC)美国, 澳大利亚, 加拿大
-
Dennis Turner, M.D.National Institute of Neurological Disorders and Stroke (NINDS); Duke University; National Institutes...主动,不招人
-
Beth Israel Deaconess Medical CenterBrigham and Women's Hospital完全的
-
Celon Pharma SANational Center for Research and Development, Poland完全的
-
Nocion Therapeutics完全的
-
Betta Pharmaceuticals Co., Ltd.尚未招聘
-
Constellation PharmaceuticalsThe Leukemia and Lymphoma Society完全的
-
Essity Hygiene and Health ABSmerud Medical Research Germany Ltd完全的
-
Onconic Therapeutics Inc.Jeil Pharmaceutical Co., Ltd.完全的
-
Sentien Biotechnologies, Inc.主动,不招人
-
University of MichiganNational Institute on Disability, Independent Living, and Rehabilitation Research完全的
-
Massachusetts General HospitalDana-Farber Cancer Institute; Infinity Pharmaceuticals, Inc.终止
-
Cornerstone Pharmaceuticals完全的
-
Infinity Pharmaceuticals, Inc.完全的
-
Celon Pharma SANational Center for Research and Development, Poland完全的
-
Iuliu Hatieganu University of Medicine and Pharmacy招聘中
-
Fusion Pharmaceuticals Inc.终止乳腺癌 | 胃癌 | 大肠癌 | 卵巢癌 | 肺癌 | 晚期实体瘤 | 头颈部鳞状细胞癌 | 肝癌 | 膀胱癌 | 易感 FGFR3 基因改变 | FGFR3 | FGFR3 过表达 | FGFR3受体 | FGFR3 蛋白过表达美国, 澳大利亚